CASTELLI, ROBERTO
CASTELLI, ROBERTO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Massive right atrial thrombosis : are you brave enough to start anticoagulation? A case report
2021 M. Bergonti, C. Ascione, P. Agostoni, R. Castelli, C. Vignati
Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation
2019 R. Castelli, P. Gallipoli, R. Schiavon, T. Teatini, G.L. Deliliers, L. Bergamaschini
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas
2018 R. Castelli, L.C. Bergamaschini, G.L. Deliliers
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency : clinical and molecular characterization
2018 M. Sbattella, A. Zanichelli, P. Ghia, V. Gattei, C. Suffritti, T. Teatini, M. Cicardi, R. Castelli
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation
2018 R. Castelli, P. Gallipoli, R. Schiavon, T. Teatini, G.L. Deliliers, L.C. Bergamaschini
Personalized treatment strategies for elderly patients with myelodysplastic syndromes
2017 R. Castelli, L.C. Bergamaschini, R. Schiavon, G. Lambertenghi Deliliers
ELEVATA INCIDENZA DI LINFOMI INDOLENTI NON FOLLICOLARI NEI PAZIENTI CON CARENZA ACQUISITA DI INIBITORI DELLA C1 ESTERASI
2016 R. Castelli
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency
2016 R. Castelli, M.A. Wu, M. Arquati, A. Zanichelli, C. Suffritti, D. Rossi, M. Cicardi
High rate of hepatitis B viral breakthrough in elderly non-Hodgkin lymphomas patients treated with Rituximab based chemotherapy
2016 R. Castelli, L. Ferraris, G. Pantaleo, G. Lambertenghi Deliliers, M. Cicardi
Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization
2015 R. Castelli, M. Cugno, U. Gianelli, A. Pancrazzi, A.M. Vannucchi
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis
2015 U. Gianelli, A. Iurlo, D. Cattaneo, A. Bossi, I. Cortinovis, C. Augello, A. Moro, F. Savi, R. Castelli, C. Brambilla, P. Bianchi, M. Primignani, A. Cortelezzi, S. Bosari
Choosing treatment options for patients with relapsed/refractory multiple myeloma
2014 R. Castelli, N. Orofino, A. Losurdo, R. Gualtierotti, M. Cugno
Pulmonary embolism in elderly patients: prognostic impact of the Cumulative Illness Rating Scale (CIRS) on short-term mortality
2014 R. Castelli, P. Bucciarelli, F. Porro, F. Depetri, M. Cugno
Rheumatoid factors : clinical applications
2013 F. Ingegnoli, R. Castelli, R. Gualtierotti
Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies : from pathophysiology to the clinic
2013 R. Castelli, A. Zanichelli, M. Cugno
Immunomodulatory drugs : new options for the treatment of myelodysplastic syndromes
2013 R. Castelli, R. Cassin, A. Cannavò, M. Cugno
Acquired C1-inhibitor deficiency and lymphoproliferative disorders : a tight relationship
2013 R. Castelli, A. Zanichelli, M. Cicardi, M. Cugno
Current and Emerging Treatment Options for Patients with Relapsed Myeloma
2013 R. Castelli, R. Gualtierotti, N. Orofino, A. Losurdo, S. Gandolfi, M. Cugno
Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy : clinical report of three patients
2012 R. Castelli, G. Gritti, A. Cannavò, G. Moreo, G. Conti, G. Reda, A. Cortelezzi
Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women : effect of weight loss obtained by gastric banding
2012 M. Cugno, R. Castelli, D. Mari, E. Mozzi, M.A. Zappa, M. Boscolo-Anzoletti, G. Roviaro, P.M. Mannucci